Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Skye Bioscience, Inc. (NMUS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  0.00.00.00.00.00.00.00.0
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.00.00.00.00.00.00.00.0
            Gross margin          
Selling, general and administrative   [+]6.14.94.34.44.43.53.53.7
Research and development  6.02.91.92.20.30.30.90.6
EBITDA   [+]-12.0-7.8-6.3-6.6-4.7-3.9-4.5-4.3
            EBITDA margin          
Depreciation and amortization  0.10.00.00.00.00.00.00.0
EBIT   [+]-12.1-7.8-6.3-6.6-4.7-3.9-4.5-4.3
            EBIT margin          
Non-recurring items   [+]6.2       
Interest expense, net   [+]0.60.80.71.00.10.0  
Other income (expense), net   [+]-0.50.10.48.7-14.40.81.3-0.5
Pre-tax income  -19.5-8.5-6.61.1-19.2-3.1-3.2-4.8
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate     0.2%    
Net income  -19.5-8.5-6.61.1-19.2-4.1-3.5-4.8
            Net margin          
   
Basic EPS   [+]($0.04)($0.02)($0.03)$0.01($0.16)($0.15)($0.18)($0.29)
Diluted EPS   [+]($0.04)($0.02)($0.03)$0.01($0.16)($0.15)($0.18)($0.29)
   
Shares outstanding (basic)   [+]555.3406.6230.7135.2121.227.918.916.9
Shares outstanding (diluted)   [+]555.3406.6231.4169.6121.227.918.916.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy